Literature DB >> 16421244

When is quarantine a useful control strategy for emerging infectious diseases?

Troy Day1, Andrew Park, Neal Madras, Abba Gumel, Jianhong Wu.   

Abstract

The isolation and treatment of symptomatic individuals, coupled with the quarantining of individuals that have a high risk of having been infected, constitute two commonly used epidemic control measures. Although isolation is probably always a desirable public health measure, quarantine is more controversial. Mass quarantine can inflict significant social, psychological, and economic costs without resulting in the detection of many infected individuals. The authors use probabilistic models to determine the conditions under which quarantine is expected to be useful. Results demonstrate that the number of infections averted (per initially infected individual) through the use of quarantine is expected to be very low provided that isolation is effective, but it increases abruptly and at an accelerating rate as the effectiveness of isolation diminishes. When isolation is ineffective, the use of quarantine will be most beneficial when there is significant asymptomatic transmission and if the asymptomatic period is neither very long nor very short.

Entities:  

Mesh:

Year:  2006        PMID: 16421244      PMCID: PMC7109638          DOI: 10.1093/aje/kwj056

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  27 in total

1.  Transmission dynamics and control of severe acute respiratory syndrome.

Authors:  Marc Lipsitch; Ted Cohen; Ben Cooper; James M Robins; Stefan Ma; Lyn James; Gowri Gopalakrishna; Suok Kai Chew; Chorh Chuan Tan; Matthew H Samore; David Fisman; Megan Murray
Journal:  Science       Date:  2003-05-23       Impact factor: 47.728

2.  Quarantine in severe acute respiratory syndrome (SARS) and other emerging infectious diseases.

Authors:  Jane Speakman; Fernando González-Martín; Tony Perez
Journal:  J Law Med Ethics       Date:  2003       Impact factor: 1.718

3.  Modelling potential responses to severe acute respiratory syndrome in Japan: the role of initial attack size, precaution, and quarantine.

Authors:  H Nishiura; K Patanarapelert; M Sriprom; W Sarakorn; S Sriyab; I Ming Tang
Journal:  J Epidemiol Community Health       Date:  2004-03       Impact factor: 3.710

4.  Efficiency of quarantine during an epidemic of severe acute respiratory syndrome--Beijing, China, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-10-31       Impact factor: 17.586

5.  Public health interventions and SARS spread, 2003.

Authors:  David M Bell
Journal:  Emerg Infect Dis       Date:  2004-11       Impact factor: 6.883

6.  Predicting super spreading events during the 2003 severe acute respiratory syndrome epidemics in Hong Kong and Singapore.

Authors:  Yuguo Li; Ignatius T S Yu; Pengcheng Xu; J H W Lee; Tze Wai Wong; Peng Lim Ooi; Adrian C Sleigh
Journal:  Am J Epidemiol       Date:  2004-10-15       Impact factor: 4.897

Review 7.  Severe acute respiratory syndrome: review and lessons of the 2003 outbreak.

Authors:  Umesh D Parashar; Larry J Anderson
Journal:  Int J Epidemiol       Date:  2004-05-20       Impact factor: 7.196

8.  Asymptomatic severe acute respiratory syndrome-associated coronavirus infection.

Authors:  Harold K K Lee; Eugene Y K Tso; T N Chau; Owen T Y Tsang; K W Choi; Thomas S T Lai
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883

9.  Predicting quarantine failure rates.

Authors:  Troy Day
Journal:  Emerg Infect Dis       Date:  2004-03       Impact factor: 6.883

Review 10.  SARS: epidemiology.

Authors:  Moira Chan-Yeung; Rui-Heng Xu
Journal:  Respirology       Date:  2003-11       Impact factor: 6.424

View more
  48 in total

1.  Threshold dynamics of a non-autonomous SEIRS model with quarantine and isolation.

Authors:  Mohammad A Safi; Mudassar Imran; Abba B Gumel
Journal:  Theory Biosci       Date:  2012-01-06       Impact factor: 1.919

2.  Comparing nonpharmaceutical interventions for containing emerging epidemics.

Authors:  Corey M Peak; Lauren M Childs; Yonatan H Grad; Caroline O Buckee
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-28       Impact factor: 11.205

Review 3.  Physical interventions to interrupt or reduce the spread of respiratory viruses.

Authors:  Tom Jefferson; Chris B Del Mar; Liz Dooley; Eliana Ferroni; Lubna A Al-Ansary; Ghada A Bawazeer; Mieke L van Driel; Sreekumaran Nair; Mark A Jones; Sarah Thorning; John M Conly
Journal:  Cochrane Database Syst Rev       Date:  2011-07-06

4.  Quarantine.

Authors:  Eric A Coomes; Jerome A Leis; Wayne L Gold
Journal:  CMAJ       Date:  2020-03-20       Impact factor: 8.262

5. 

Authors:  Eric A Coomes; Jerome A Leis; Wayne L Gold
Journal:  CMAJ       Date:  2020-10-13       Impact factor: 8.262

6.  Community-based measures for mitigating the 2009 H1N1 pandemic in China.

Authors:  Sanyi Tang; Yanni Xiao; Youping Yang; Yicang Zhou; Jianhong Wu; Zhien Ma
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

7.  Including the public in pandemic planning: a deliberative approach.

Authors:  Annette J Braunack-Mayer; Jackie M Street; Wendy A Rogers; Rodney Givney; John R Moss; Janet E Hiller
Journal:  BMC Public Health       Date:  2010-08-19       Impact factor: 3.295

Review 8.  Does influenza transmission occur from asymptomatic infection or prior to symptom onset?

Authors:  Eleni Patrozou; Leonard A Mermel
Journal:  Public Health Rep       Date:  2009 Mar-Apr       Impact factor: 2.792

9.  Cochrane Review: Interventions for the interruption or reduction of the spread of respiratory viruses.

Authors:  Tom Jefferson; Ruth Foxlee; Chris Del Mar; Liz Dooley; Eliana Ferroni; Bill Hewak; Adi Prabhala; Sreekumaran Nair; Alessandro Rivetti
Journal:  Evid Based Child Health       Date:  2008-12-10

10.  Public perceptions of quarantine: community-based telephone survey following an infectious disease outbreak.

Authors:  C Shawn Tracy; Elizabeth Rea; Ross E G Upshur
Journal:  BMC Public Health       Date:  2009-12-16       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.